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Abstract
To establish bovine spongiform encephalopathy (BSE) public health protection measures it is important to precisely
define the cattle tissues considered as specified risk materials (SRM). To date, in pre-clinical BSE infected cattle, no
evidence of the BSE agent had been found in the gut outside of the ileal Peyer’s Patches. This study was
undertaken to determine when and where the pathological prion protein (PrPSc) and/or BSE infectivity can be
found in the small intestine of cattle 4 to 6 months of age, orally challenged with BSE. Samples of the jejunum, the
ileum and the ileocaecal junction from 46 BSE infected cattle, culled from 1 up to 44 months post infection (mpi)
were examined by immunohistochemistry. Samples from cattle 8 mpi to 20 mpi were additionally studied by PTA
Western blot, rapid tests, and by mouse (TgbovXV) bioassay. In doing so nearly all of the cattle, from 4 up to 44
mpi, had detectable amounts of PrPSc and/or infectivity in the distal ileum. In the distal ileum clear time-
dependent variations were visible concerning the amount of PrPSc, the tissue structures affected, and the cells
involved. BSE infectivity was found not only in the ileum and ileocaecal junction but also in the jejunum. The
systematic approach of this study provides new data for qualitative and quantitative risk assessments and allows
defining bovine SRM more precisely.
Introduction
Transmissible spongiform encephalopathies (TSE) are a
group of fatal neurodegenerative diseases affecting a wide
range of hosts including scrapie in sheep and goats,
chronic wasting disease in cervidae as well as Creutz-
feldt-Jakob disease in humans. The hallmark of these dis-
eases is the accumulation of a disease-associated partially
Protease-resistant isoform (PrPSc) resulting from the con-
version of the host-encoded membrane-bound glycopro-
tein, cellular prion protein (PrPc).
Bovine specified risk materials (SRM) are tissues
which are considered to possibly contain bovine spongi-
form encephalopathy (BSE) infectivity in incubating ani-
mals. These tissues are banned for the use in human
food and health products because of the potential risks
of transmission of BSE to consumers and the attendant/
further development of variant Creutzfeldt-Jakob dis-
ease. Currently the list of bovine SRM varies between
countries, including those of the European Union and
North America. No international SRM regulations exist.
For example, the small intestine from cattle of all ages is
banned for use in the EU whereas in North America
only the distal ileum is banned. As a consequence pro-
ducts such as beef casings, which are produced from the
jejunum, are banned from human consumption in the
EU but not in North America.
The scientific basis for the current SRM regulations
concerning the gut is based on the wide distribution of
infectivity in the intestine of TSE infected sheep and on
BSE studies that have had a limited scope. In these stu-
dies BSE infectivity and the detection of PrPSc was lim-
ited to the distal ileum of the small intestine. In the
distal ileum of experimentally infected cattle both PrPSc,
beginning at 10 months post infection (mpi), and BSE
infectivity, at 6 mpi, were detected [1-4]. The distal
ileum of naturally occurring cases has also been shown
to contain PrPSc and/or BSE infectivity [3,5,6]. Immuno-
histochemical examinations of the distal ileum revealed
PrPSc accumulations in Peyer’s Patches (PP) as well as
in the enteric nervous system (ENS) in an age depen-
dent manner [2,3]. Younger, orally infected animals up
to 36 mpi showed only a staining reaction in a small
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proportion of their follicles in the Peyer’s Patches of the
distal ileum [2,3]. Therein the accumulation of PrPSc is
initially confined to tingible body macrophages but in
the later clinical disease phase a reaction pattern resem-
bling follicular dendritic cells (FDC) can be seen. A
positive staining reaction of the ENS is restricted to
clinical cases and is the only accumulation detectable in
the distal ileum of natural occurring infections [3,6].
However, evidence for BSE infectivity or PrPSc accumu-
lations in other parts of the bovine small intestine, other
than the distal ileum, has not been convincingly demon-
strated for either experimentally or naturally occurring
cases.
Up to a year of age, the ileal PP represent the major
gut-associated lymphoid tissue in ruminants possessing
an extensive bed of follicular dendritic cells and a spe-
cialised epithelium actively engaged in the uptake and
transcytosis of macromolecules from the gut, explaining
the restriction of PrPSc to this region of the gut [7].
How TSE agents cross the epithelium is not exactly
known but several mechanisms have been proposed.
The first is via the M-cells, a cell type which is asso-
ciated with the epithelium of the gut and capable to
transcytose the scrapie agent in vitro [8]. A recent scra-
pie study showed that PrPSc was transported across the
absorptive epithelium of villi into lacteals in vivo [9].
The transmission route using a direct uptake by dendri-
tic cells that can acquire antigens directly from the
intestinal lumen cannot be ruled out [10,11]. After
crossing the mucosal barrier TSE infectivity and PrPSc
first accumulates in the PP and this replication is
thought to facilitate further neuro-invasion [12,13]. In
this model neuro-invasion would take place between the
submucosal plexus of the ENS and PP though pathways
which have yet to be ascertained [14,15]. However
neuro-invasion can occur without apparent involvement
of the lympho-reticular system (LRS) in different species
suggesting a direct route of infection via the submucosal
network of nerve fibres [16] which contains nerves that
are present directly adjacent to the basement membrane
of villous epithelium [9].
The study presented here concerned cattle of all age
groups but focused on the small intestines of pre-clinical
BSE cattle and in particular on younger animals between
4 to 24 months of age, because the majority of consu-
mer beef and beef by-products come from that age
group. The study determined when BSE infectivity and/
or accumulations of PrPSc can be found in the small
intestine of cattle between the ages of 4 to 6 months
which were orally challenged with BSE. To our knowl-
edge this is the first study investigating extensively not
only the ileum/ileocaecal-junction but also the jejunum
of cattle in preclinical stages of BSE. The results pre-
sented provide data for inclusion to qualitative and
quantitative risk assessments and give new insights into
the early gut associated pathogenesis of BSE.
Materials and methods
Ethical Approval
The challenge experiments in cattle and mice described
in this manuscript were approved by the competent
authority of the Federal State of Mecklenburg-Western
Pommerania, Germany on the basis of national and
European legislation, namely the EU council directive
86/609/EEC for the protection of animals used for
experiments.
Animals
Within the German BSE pathogenesis study 56 Simmen-
tal calves ages 4 to 6 months were orally challenged
with classical BSE using a brain stem homogenate pool
of clinically diseased cattle. The infectivity load in the
homogenate was approximately 106.1 ID50/g tissue as
determined by end-point titration in Tgbov XV mice
[2,5]. Furthermore, as controls 18 calves were inoculated
orally with a BSE-negative brainstem homogenate. Every
4 months 2-5 animals were randomly selected and killed
and a wide range of tissue samples were taken under
TSE-sterile conditions.
From this herd 46 challenged (1-44 mpi) and two con-
trol cows (12 and 24 mpi) were included in the study
presented here (Figure 1). Listed in Table 1 are all ani-
mals chosen and the most important anamnestic data.
Tissue samples
The number and location of samples examined as well
as the methods applied depended on the age of the ani-
mals. An overview is given in Figures 1 and 2.
Four samples of the small intestine, two areas from
jejunum and one from each the ileum and ileocaecal-
junction were examined from all animals in the group
consisting of 1-24 mpi, including the controls (n = 27).
All samples were examined by immunohistochemistry,
but a core group of 24 cattle (including the controls) in
the groups from 4 to 24 mpi underwent additional bio-
chemical tests, described below. A subset of that group
(n = 18, including controls) in the ages from 8 mpi to
20 mpi, were included in a mouse bioassay.
In the age groups from 28 to 44 mpi ileal samples
(n = 21) and also samples from the ileocaecal-junction
(n = 11) and jejunum (n = 3) were collected and exam-
ined by immunohistochemistry only.
All tissue samples clearly contained PP but due to the
limited amount two different PP from the same area of the
small intestine were therefore used. Frozen PP were used
to conduct the bioassay and biochemical tests and formalin
fixed PP were used to conduct the immunohistochemical
examinations. A schematic drawing illustrating the areas of
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the small intestine from which the tissue samples were
taken, as well as slides of PP showing their allocations
according to the methods applied, is shown in Figure 2.
Immunohistochemistry
With some modifications, tissue samples were processed
as described previously [17]. The tissues were fixed in
4% neutral buffered formalin for at least two weeks. The
samples were treated for 1 h with 98% formic acid and
rinsed in tap water for 40 min before dehydration and
embedding in paraffin.
A single three micrometer section prepared and
mounted on a Superfrost plus slide (Menzel-Gläser,
Braunschweig, Germany) reflects a minimal area of the
tissue sample to be examined. Therefore a serial section
procedure was newly established at the Friedrich-Loef-
fler-Institut to increase the total amount of tissue struc-
tures examined per sample and consequently increasing
the probability in the detection of PrPSc accumulation.
We examined five areas per paraffin block with a spatial
distance about 25-30 μm. Hence, a depth of about 150-
200 μm per block was achieved.
Two different PrP-specific monoclonal antibodies
(mab), highly sensitive for the detection of bovine PrPSc
were used. These were mabs 12F10 (Cayman Chemical,
Ann Arbor, Michigan, USA) and 6C2 (Central Veterin-
ary Institute of WageningenUR, Lelystad, Netherlands)
[18]. Before using mab12F10 the sections had been pre-
treated by subsequent incubation for 15 min in 98%
formic acid, rinsed in tap water, the inhibition of
endogenous peroxidase with 3% H2O2 (Merck, Darm-
stadt, Germany) in methanol for 30 min, followed by a
15 min digestion with proteinase K (4 μg/mL, Boehrin-
ger Mannheim, Germany) at 37°C. Before using mab
6C2 the sections had been incubated for 30 min in for-
mic acid, rinsed in tap water and subsequently auto-
claved in citrate buffer for 20 min at 121°C. These
primary antibodies were applied at a dilution of 1:500
(12F10, stock concentration 200 μg/mL) and 1:50 (6C2,
stock concentration 36 μg/mL) in goat serum and incu-
bated for 2 h at room temperature. Negative control
sections were treated with a mab against GP5 pf porcine
respiratory and reproductive syndrome virus. As a sec-
ondary antibody we used the EnVision™ reagent (Dako,
Hamburg, Germany) containing a peroxidase-conjugated
polymer backbone. Incubation time on these sections
was 30 min at room temperature. The slides were finally
developed in diaminobenzidine tetrahydrochloride
(Fluka, Steinheim, Germany) and counterstained with
Mayer’s haematoxylin. All sections were examined by
light microscopy.
Rapid tests
Frozen samples of the four small intestine sites from 22
infected and 2 control cattle sacrificed between 4 and
24 mpi were tested by BioRad TeSeE (München, Ger-
many) and IDEXX HerdChek (Ludwigsburg, Germany)
rapid tests following the manufacturers’ instructions.
Optical density (OD) values more than twofold of
the cut-off were defined as clear reactive samples. In
Figure 1 Schematic overview showing the different methods applied and the animals concerned. mpi = months post infection, *plus one
control cow.
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Table 1 Overview concerning anamnestic data of the cows and immunohistochemical results of all samples examined
Months
p.i.
Cow Status PrPSc in the
Obex (IHC)
Ileum Ileocaec.-junct. Jejunum
No. pos. Foll./
Total No. Foll.
No. pos.
Foll. in %
TBM/Intracellular
Reaction Pattern
FDC ENS No. pos. Foll./
Total No. Foll.
No. pos. Foll./
Total No. Foll.
1 (n = 3) IT 04 preclinical negative 0/9189 0 – – – 0/3289 0/1337
IT 44 preclinical negative 0/6272 0 – – – 0/912 0/761
IT 62 preclinical negative 0/4634 0 – – – 0/721 0/9479
4 (n = 2) IT 19 preclinical negative 1/4076 0.02 punctate – – 0/102 0/848
IT 45 preclinical negative 4/4399 0.09 punctate – – 0/162 0/1453
IT 14 preclinical negative 0/726 0 – – – 0/394 0/1256
8 (n = 4) IT 20 preclinical negative 15/2554 0.6 punctate/fine
granular
– – 0/1037 0/2636
IT 39 preclinical negative 1/1309 0.07 punctate – – 0/601 0/457
IT 55 preclinical negative 1/2285 0.04 punctate – – 0/279 0/475
12 (n = 4) IT 01 preclinical negative 89/461 19.3 punctate/fine
granular
(+)* – 0/352 0/437
IT 16 preclinical negative 3/1711 0.2 punctate – – 0/1252 0/1135
IT 06 preclinical negative 56/957 5.8 fine granular/
globular
(+)* –. 3/418 0/201
IT 57 preclinical negative 65/1384 4.7 fine granular/
globular
(+)* – 0/1251 0/495
16 (n = 4) IT 07 preclinical negative 0/135 0 – – – 0/909 0/325
IT 28 preclinical negative 4/1514 0.3 fine granular/
globular
+ + 6/1149 0/550
IT 46 preclinical negative 0/708 0 – – – 0/510 0/970
IT 65 preclinical negative 8/2483 0.3 fine granular (+) – 0/975 0/1112
20 (n = 4) IT 10 preclinical negative 0/774 0 – – – 0/580 0/1187
IT 17 preclinical negative 1/1369 0.07 fine granular/
globular
– – 26/1456 0/1004
IT 50 preclinical negative 1/611 0.2 globular – – 0/449 0/712
IT 60 preclinical negative 2/902 0.2 fine granular/
globular
+ – 0/699 0/265
24 (n = 4) IT 26 preclinical positive 35/389 9.0 globular + +++ 0/819 0/996
IT 24 preclinical negative 29/438 6.6 globular + + 0/1037 0/1999
IT 47 preclinical negative 89/343 25.9 fine granular (+) + 0/511 0/1114
IT 58 preclinical negative 0/86 0 – – – 4/1027 0/1473
28 (n = 4) IT 08 preclinical positive 6/508 1.2 fine granular (+) + 0/182 n.d.
IT 21 preclinical positive 4/489 0.8 fine granular – – n.d. n.d.
IT 51 preclinical negative 1/854 0.1 fine granular – – 0/669 n.d.
IT 52 preclinical negative 2/1574 0.1 punctate – – n.d. n.d.
32 (n = 4) IT 05 preclinical positive 0/114 0 – – + 0/1278 n.d.
IT 09 clinical positive 10/54 18.5 fine granular/
globular
+ +++ n.d. n.d.
IT 43 clinical positive 11/694 1.6 fine granular/
globular
(+) – 0/569 n.d.
IT 61 clinical positive 7/291 2.4 fine granular/
globular
(+) – n.d. n.d.
36 (n = 4) IT 49 clinical positive 12/314 3.8 fine granular (+) + n.d. n.d.
IT 48 preclinical negative 2/473 0.4 globular – – 0/1306 n.d.
IT 11 clinical positive 0/349 0 – – ++ n.d. n.d.
IT 23 clinical positive 14/177 7.9 globular + +++ 0/602 n.d.
40 (n = 4) IT 13 clinical positive 15/385 3.9 fine granular/
globular
(+)* ++ 0/750 n.d.
IT 25 clinical positive 0/45 0 – – ++ n.d. n.d.
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contrast low reactivity samples, showing OD values
weakly above the cut-off were defined as inconclusive.
PTA-Western blot
The samples chosen for the rapid tests were also investi-
gated for the accumulation of PrPSc by western blotting
using phosphotungstic acid precipitation (PTA-WB).
The tests were carried out according to a previously
established protocol [19,20] with some modifications
described elsewhere [21]. Samples which showed an
ambiguous band pattern after Proteinase-K treatment
were defined as inconclusive.
Bioassay (Tgbov XV mice)
Bioassays were performed on samples collected from ani-
mals sacrificed between 8 and 20 mpi using transgenic
mice over-expressing bovine PrP (Tgbov XV) [5]. Groups
of 15 mice were intra-cerebrally inoculated with 30 μL of
10% tissue homogenates diluted in sterile 0.9% sodium
chloride. All tissue homogenates were semi-sterile on
blood agar plates but regrettably 17 of them were highly
toxic for mice (i.e. more than 5 animals died per inocula-
tion group). In these cases the necessary number of mice
was reached by additional inoculations using residual
inocula that were heat treated for ten minutes at 70°C. All
mice were assessed for the onset of clinical symptoms at
least twice weekly. Mice showing clinical signs were sacri-
ficed and their brains tested for the accumulation of PrPSc
by a PTA immunoblotting method as described before [2].
Results
We examined the gut associated pathogenesis of classi-
cal BSE by mapping the exact temporal and spatial
emergence and distribution of PrPSc in the gut asso-
ciated lymphoid tissues (GALT) of the small intestines
of pre-clinical cattle.
The histopathological examination revealed for all
samples, including the controls an eosinophilic enteritis,
varying in degrees from moderate to severe. The cause
was most likely due to a mild coccidiosis, as shown by
light microscopy in some animals.
A total of 40 out of 46 orally BSE infected animals
showed detectable amounts of PrPSc and/or infectivity.
The positive reactions were in most cases (n = 28) con-
fined to the distal ileum, but infectivity could also be
detected in all parts of the small intestine simulta-
neously. All methods applied revealed a wider and a
more constant distribution of PrPSc or infectivity in
younger cattle at 8 mpi and in particular at 12 mpi, as
compared to later stages of the incubation period. All
control cows examined revealed negative results by the
different methods applied. An overview and comparison
of the most important results obtained by the different
methods used is shown by Table 2.
Ileum
One cow out of the eight mpi (IT39) group and all cows
from the 12 mpi group revealed positive and/or incon-
clusive results in the biochemical tests applied. However,
in all samples examined there were no positive reactions
by using the BioRad TeSeE rapid test. With the IDEXX
HerdChek rapid test, clear reactive samples were
detected in the distal ileum of two cows (IT01 and
IT57), both at 12 mpi. Inconclusive samples were seen
with three cattle at 8 mpi (IT39) and 12 mpi (IT16,
IT06). Furthermore four of the cows (IT39, IT01, IT06,
IT57) had distinct PrPSc accumulation using PTA-WB.
After Proteinase-K treatment one sample (IT16), had an
ambiguous band pattern. This sample was therefore
defined as inconclusive.
There were differences in the apparent level of infec-
tivity between the different parts of the small intestine
(Table 3). The ileal samples showed the highest level of
infectivity with the shortest incubation period (mean
value 320 days) and the highest transmission rates (more
than 2/3 of mice were affected) as compared to the jeju-
nal and ileocaecal-junction samples. Infectivity in the dis-
tal ileum was detected in 11 of the 16 infected cattle
Table 1 Overview concerning anamnestic data of the cows and immunohistochemical results of all samples examined
(Continued)
IT 56 preclinical positive 1/661 0.2 fine granular – + n.d n.d.
IT 41 preclinical positive 0/112 0 – – +++ 0/564 n.d.
44 (n = 4) IT 15 clinical positive 1/121 0.8 fine granular – + 0/546 453
IT 22 clinical positive 0/215 0 – – +++ n.d. n.d.
IT 02 clinical positive 0/131 0 – – ++ 1*/724 859
IT 53 clinical positive 3/480 0.6 fine granular/
globular
– + 0/690 1390
IT 38 clinical positive 0/155 0 – – – n.d. n.d.
TBM: Tingible Body Macrophages, n.d.: not done, * only seen with mab 6C2, pos: positive, Foll: Follicle.
ENS: total number of positive labelled foci in the ENS (submucosal and myenteric plexuses), +:0-4 positive foci in the ENS, ++: 5-10 positive foci in the ENS, +++:
> 11 positive foci in the ENS.
FDC: (+): weak dendritic network, +: clear dendritic network.
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Figure 2 Schematic overview concerning the localisation and allocation of the Peyer’s patches (PP) used. Ia/Ib: two localisation of jejunal
PP’s, II: ileal PP, III: ileocaecal-junction, A: Bioassay (0.150 g), B: BioRad TeSeE (0.220 g), C: IDEXX HerdChek (0.350 g), D: PTA-Immunoblot (0.170 g),
E: additional PP fixed in 4% neutral buffered formalin.
Table 2 Overview and comparison of the results obtained by the different methods used (clear positive results are
marked)
M.p.i. Cow Jejunum (localization A+B) Ileum Ileocaecal juction
IDEXX PTA IHC Bioassay IDEXX PTA IHC Bioassay IDEXX PTA IHC Bioassay
4 (n = 2) IT 19 – – – n.d. – – + n.d. – – – n.d.
IT 45 – – – n.d. – – + n.d. inconcl – – n.d.
IT 14 – – – – – – – + – – – –
8 (n = 4) IT 20 – – – – – – + + – – – –
IT 39* inconcl inconcl – + inconcl + + + – – – –
IT 55 – – – + – – + + – – – +
12 (n = 4) IT 01 – – – + + + + + inconcl + – +
IT 16 – – – – inconcl inconcl + + – inconcl – +
IT 06 – – – + inconcl + + + – inconcl + +
IT 57 – – – + + + + + + + + +
16 (n = 4) IT 07 – – – – – – – – – – – –
IT 28 – – – – – – + – – – + –
IT 46 – – – – – – – – – – – –
IT 65 – – – – – – + + – – – +
IT 10 – – – + – – – – inconcl – – –
20 (n = 4) IT 17 – – – – – – + – – + + +
IT 50 – – – – – – + + inconcl – – –
IT 60 – – – + – – + + – – – –
24 (n = 4) IT 26 – – – n.d. – – + n.d. – – – n.d.
IT 24 – – – n.d. – – + n.d. – – – n.d.
IT 47 – inconcl – n.d. – – + n.d. – – – n.d.
IT 58 – – – n.d. – – – n.d. – – + n.d.
n.d.: not done, +: clear positive result, –: negative result, inconcl: inconclusive, *: both jejunal samples of the IT 39 had inconclusive reaction patterns but positive
bioassay is from localization A only.
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examined by bioassay. The younger cattle, at 8 mpi and
12 mpi, showed a wider and a more constant distribution
of infectivity than the older animals. Consequently the
highest amount of infectivity was seen in samples exam-
ined at 12 mpi, and the lowest at 16 mpi.
Detectable amounts of PrPSc were found in the Ileum
of 37 out of the 46 cattle examined by immunohisto-
chemistry. In total 31 cattle showed an accumulation
of PrPSc in the follicles of the ileal PP. Thereby clear
quantitative and qualitative age-related variations in
the PrPSc accumulations were visible. From 4 mpi to
36 mpi the PrPSc was visible in most of the cattle but
in the later stages of the incubation period only single
animals revealed a detectable amount of PrPSc. An
obvious undulant pattern was found when counting
the follicles with a positive staining reaction as com-
pared to the total numbers of follicles examined. In
doing so the first traces of PrPSc (less than 1% of the
follicles examined) was observed in the 4 mpi group,
followed by an abrupt rise in the numbers of positive
follicles (up to 20%) at 12 mpi. Within the 16 mpi and
20 mpi group only traces of PrPSc were seen again
(less than 1% of the follicles examined). However, as
seen in the 12 mpi group a high number of positive
follicles, up to 25%, were seen at 24 mpi. In contrast
animals within the group 28 mpi which only revealed
approximately 1% positive follicles. Later stages of the
incubation period did not show such clear variations,
but higher numbers of positive reactive follicles were
observed in single animals at 32, 36, and 40 mpi. No
clustering of positive stained follicles was seen in any
of the samples.
The cellular reaction patterns of PrPSc (Table 1)
observed was in a time-dependent manner. With the
increase in the number of positive follicles there was a
simultaneous increase in the number of cells accumulat-
ing PrPSc. The first detectable amounts of PrPSc were
confined to large mononuclear cells, resembling tingible
body macrophages (TBM). Initially a few intra-cytoplas-
matic granules were only detectable in a few cells.
These single punctas within the TBM’s (Figure 3A)
increased over the incubation period showing, at first, a
fine multigranular intracellular appearance followed by a
more globular accumulation (Figure 3B), seen in several
cells of one follicle. The positive stained cells were
mainly located in the light central zones of the follicles
and less commonly within the dark zones. A curvilinear
staining reaction, mostly seen with the mab 6C2, resem-
bling the follicular dendritic cell (FDC) was observed in
single follicles and was associated with an increase of
positive stained cells. Initially a very weak linear reaction
pattern was observed at 12 mpi and a more distinct net-
like staining reaction later in the incubation period with
a peak at 24 mpi (Figure 3B).
Accumulation of PrPSc in the ENS was observed in 18 of
the 46 cattle examined. It was first detected at 16 mpi
(IT28). Only a few animals showed detectable amounts of
PrPSc up to an incubation period of 32 mpi, with a peak at
24 mpi. In these age groups mainly individual plexuses are
concerned (Table 1). In contrast, later in the incubation
period most of the animals which stained positive in the
ENS showed a wider distribution of PrPSc within several
multifocal distributed plexus. In all cattle, the submucosal
layer, as well as the myenteric plexuses, was involved but
Table 3 Bioassay of different localizations of bovine
small intestine in bovine transgenic mice (Tgbov XV):
results (revealed by PTA-Immunoblot), transmission rates
and incubation periods
Months
p.i.
Cow Localization
Jejunum
A
Jejunum
B
Ileum Ileocaec.
IT 14 0/10
–
0/14
–
9/13
280 ± 41
0/15
–
8 IT 20 0/14*
–
0/13
–
8/11
334 ± 61
0/15*
–
IT 39 1/14*
502
0/12*
–
7/11*
310 ± 49
0/12
–
IT 55 2/10*
379, 522
0/12
–
7/9
332 ± 47
3/13
442, 517,
582
12 IT 01 0/14*
–
3/10
407, 432,
600
12/13
305 ± 45
14/15
315 ± 40
IT 16 0/13
–
0/12
–
6/11
412 ± 31
1/10
395
IT 06 0/12
–
1/13
375
10/10
279 ± 47
12/12
277 ± 39
IT 57 0/15
–
2/10
393, 428
11/11
260 ± 55
9/11
297 ± 64
IT 07 0/14*
–
0/15
–
0/12*
–
0/9
–
16 IT 28 0/11
–
0/11
–
0/11
–
0/12
–
IT 46 0/11
–
0/12
–
0/10
–
0/12
–
IT 65 0/12
–
0/11
–
11/14*
319 ± 41
13/13*
349 ± 53
20 IT 10 0/13
–
2/15
363, 408
0/11*
–
0/9
–
IT 17 0/12*
–
0/10
–
0/15*
–
12/12
311 ± 33
IT 50 0/12*
–
0/14*
–
11/13
353 ± 57
0/12*
–
IT 60 1/12
391
0/9
–
11/12
345 ± 37
0/12
–
The first line indicates the number of positive tested mice/total number of
mice, the second line indicates the mean incubation period in days post
infection.
*augmented groups - additional inoculations after heating the inoculum to
70°C for 10 min.
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the latter to a much higher degree (about three fold). An
intra-glial, intra-neuronal, peri-neuronal and more rarely a
linear reaction pattern can be seen in all plexuses indepen-
dent of the age of the animals (Figure 4A). In one cow at
12 mpi (Figures 4B and 4C) a clear intracellular staining
reaction of some cells located in the submucosa beneath
follicles of the PP was observed. An exact identification by
morphological characteristics was not possible. Clustering
of PrPSc in specific localizations/areas was rarely seen as
the affected myenteric plexuses were in most cases not
associated with adjacent positive follicles. Most of the
older animals lacked a simultaneous follicular accumula-
tion of PrPSc.
Ileocaecal-junction
Only one cow (IT57, 12 mpi) revealed a clear positive
result in the IDEXX HerdChek rapid test, but an incon-
clusive result can be seen in four cows at different time
points. While IT57 and one further cow (IT01) of
the 12 mpi group revealed a clear accumulation of PrPSc
as demonstrated by PTA-Immunoblot, both remain-
ing cows at 12 mpi showed inconclusive results.
Figure 3 PrPSc accumulation within follicles of the ileal PP. A: IT55 (8 months p.i.), note the mild, predominantly punctate (arrows) reaction
pattern within the cytoplasm of tingible body macrophages only; B: IT24 (24 months p.i.), besides a intracytoplasmatic globular reaction pattern
within the TBM’s, a clear net-like staining reaction typical for FDC can be seen; Immunohistochemistry, PrP mAb 12F10, Nomarski interference
contrast, Bars 50 μm.
Figure 4 PrPSc accumulation within the enteric nervous system (ENS). A: IT11 (36 months p.i.), neurons of the myenteric plexus with clear
perineuronal and weakly linear staining reaction; B, C: IT06 (12 months p.i.) granular staining reaction of single cells (arrows) in the submucosa
directly adjacent to follicles of the PP; Immunohistochemistry, PrP mAb 12F10, Nomarski interference contrast, Bars 20 μm.
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Additionally a clear accumulation of PrPSc can also be
seen in one cow (IT17) at 20 mpi.
Infectivity of the ileocaecal-junction was found in
seven animals, predominantly in younger cows. The
ileocaecal samples had a lower level of infectivity and
slightly prolonged incubation times as compared to the
ileal samples but had high transmission rates amongst
the mice.
In total five animals revealed a positive staining reac-
tion using immunohistochemistry. Four of them had a
simultaneous accumulation in the ileum, but one cow
(IT58, 24 mpi) displayed detectable amounts of PrPSc in
the ileocaecal-junction only. All five animals showed
detectable amounts of PrPSc in the lymphoid tissue of
the ileocaecal junction similar to the types of accumula-
tions seen in the ileal PP’s. Two cows, at 16 mpi (IT28)
and 20 mpi (IT17), had clear staining reactions in their
myenteric plexuses of the ENS as described for the
ileum. An ambiguous staining reaction was seen in the
myenteric plexus of one cow at 12 mpi (IT06).
Jejunum
Two animals had inconclusive results using the bio-
chemical tests, IT39 (8 mpi) with both the IDEXX
HerdChek rapid test and PTA-Immunoblot and IT47
(24 mpi) using the PTA-Immunoblot.
Positive bioassays were seen in seven cattle examined,
mainly in younger cows at 8 and 12 mpi (Figure 5). The
jejunal samples revealed the lowest levels of infectivity
shown in the present study with distinct longer incuba-
tion periods (about 100 days) and low transmission
rates with fewer mice per group affected.
An immunohistochemical staining reaction in the jeju-
nal samples was never seen.
Discussion
The test results showed that nearly all of the cattle (40/
46) from 1 mpi to 44 mpi carried BSE infectivity and/or
detectable amounts of PrPSc in their small intestines.
We were able to demonstrate infectivity not only in the
ileum, but also in the ileocaecal junction and in the jeju-
num and in some animals in all three anatomical loca-
tions simultaneously.
Samples for biochemical examinations and the bioas-
say were taken from one PP allowing a direct compari-
son of these methods. Clear differences in sensitivities
were observed. While the BioRad TeSeE failed to detect
any amount of PrPSc, both the IDEXX HerdChek and
the PTA-immunoblot were positive in a number of sam-
ples from the ileum/ileocaecal-junction. The most sensi-
tive test, however, was the bioassay, using bovine PrP
over-expressing transgenic mice (Tgbov XV), showing
infectivity in all parts of the small intestine. The highest
amounts of infectivity (high transmission rates, short
incubation periods) were found in the ileum, a moderate
degree in the ileocaecal junction and traces of infectivity
in the jejunum. A high sensitivity was also achieved
through IHC, using a second PP. Nearly all animals
Figure 5 PrPSc detection in Tgbov XV mice challenged with jejunal Peyer’s patches. Immunoblot displaying clear positive results in mice
brains inoculated with jejunal samples of different BSE-infected cows; lane 1, 2, 3: three different mice, inoculated with a jejunal sample from
IT01, 12 mpi; lane 4, 5: two different mice inoculated with a jejunal sample from IT57, 12 mpi; lane 6: one mouse inocuated with a jejunal
sample from IT06, 12 mpi; lane 7, 8: two different mice inoculated with a jejunal sample from IT10, 20 mpi; lane 9, 10: two different mice
inoculated with a jejunal sample from IT55, 8 mpi. Positive respectively negative cattle brains served as controls, Primary PrP mab L42.
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examined (40/46) revealed detectable amounts of PrPSc
mainly in the ileum but also in the ileocaecal-junction.
In an earlier study only approximately one third of the
cattle examined showed positive results in the distal
ileum [3]. These differences in sensitivity are most prob-
ably due to the larger number of sections prepared in
our study. For example the total number of follicles
examined here is 3-5 times higher than in comparable
studies and the same is true for the plexus numbers.
Due to the higher number of samples examined and
therefore a higher sensitivity, this allowed us not only
the very early detection of PrPSc in the ENS of a cow
(IT28) at 16 mpi, but also we were able to demonstrate
PrPSc in the ENS of one cow (IT26) which we reported
to be negative two years before [2].
The results presented here add new insights into the
gut-associated pathogenesis of BSE in cattle which
shows a clear time-dependent pattern. It has been
shown for some sheep scrapie infections that a latent
period of at least about one month after exposure
occurs during which no detectable infection is present
[9,22,23]. This time lag is supposedly due to insufficient
amounts of PrPSc for detection by immunohistochemis-
try [9,22]. A similar time-dependent pattern for the
detection of PrPSc is seen in the cattle examined here.
However, the time lag between replication of the agent
and accumulation of PrPSc in detectable amounts by
IHC seems to be approximately four months. A shorter
time-lag seems unlikely due to the only very weak
amounts of PrPSc in ileal follicles at 4 mpi. During the
first 8 mpi of BSE infection in cattle there seems to be
an equilibrium between replication, accumulation and
degradation as indicated by weak amounts of PrPSc
represented by a punctate reaction pattern in TBM’s. As
the incubation time increased, the balance changed in
favour of a massive accumulation of PrPSc in follicles of
the PP’s as seen at 12 mpi. Corresponding results are
seen with the bioassay since younger animals up to
12 mpi showed a wide distribution of infectivity affect-
ing all localizations which indicates a multifocal increase
of the BSE agent. Infectivity data for the distal ileum
presented here are compatible with those reported in
UK studies [3,4,24]. For the distal ileum a peak at
12 mpi concerned both the number of follicles involved
and the amount of PrPSc detectable in the individual fol-
licles. Most interestingly, PrPSc is detectable in FDC as
well as in TBM, indicating increased clearance activities
by the latter, as described already for scrapie [13,25].
The very low (if any) PrPSc accumulation and infectivity
loads seen at time points 16 mpi and 20 mpi also sup-
port this clearance hypothesis. Such a decrease in the
infectivity loads in ileal PP’s of BSE-infected cattle in
20 mpi animals has also been described before [26].
A second peak of PrPSc accumulation, involving both
TBM’s and FDC was seen at 24 mpi, suggesting a repli-
cation cycle (i.e. a shift of the balance between accumu-
lation and degradation in favour of accumulation) for
BSE about 12 mpi. Infectivity studies done previously
using BoPrP-Tg110 mice showed/revealed a comparable
low incubation period of 24 mpi for 1 mouse out of 5
mice [1]. Therefore infectivity data from that time point
would be of interest, and will be done in future studies.
A third peak of PrPSc accumulation in the ileal PP’s can
be demonstrated, after a clear decrease at 28 mpi, in
single cows at 32, 36 and 40 mpi, reflecting an indivi-
dual variability in older cows.
The exact route of infection for the ENS, which is
thought to be the entry point to the peripheral nervous
system, still remains unclear [27]. In particular during
the pathogenesis of BSE an accumulation of PrPSc in the
ENS has been rarely reported and was confined to clini-
cal cases [3,6]. In contrast, in sheep scrapie a wide dis-
tribution of PrPSc in the ENS occurs, often associated
with abundant deposits of PrPSc in the adjacent PP’s
[14,28] indicating an infection of the ENS via the
GALT. However, a direct route via nerve fibres under-
neath the villous epithelium is also discussed [9,15]. In
the study presented here evidence for both routes of
infection can be seen. We observed one cow at 12 mpi
which had a slight staining reaction in the submucosa
directly adjacent to a follicle, which might reflect an
early neuro-invasion of a submucosal plexus. Unfortu-
nately we were not able to clearly characterize the cells
involved and macrophages penetrating the submucosa
can not completely be ruled out. The first clear evidence
for an ENS infection is seen in a single myenteric plexus
at 16 mpi without adjacent follicles staining. Moreover,
it is striking that in younger cows the accumulations of
PrPSc were confined to single plexuses, whereas later in
the incubation period, in particular associated with end-
stage BSE, the number of affected plexuses increased.
However, in most of the samples examined a randomly
distributed pattern of affected myenteric plexuses is
obvious, a clear association to affected follicles is not
seen suggesting a direct neuro-invasion without an
involvement of the GALT. Nevertheless these results
clearly indicate that the ENS is involved in the early
propagation of PrPSc, but to a much lesser extend as
compared to scrapie. Furthermore, the marginally higher
number of affected plexus seen in clinical cases in com-
bination with their multifocal distribution pattern could
be due to a local accumulation over time, but a limited
spread along the ENS cannot be completely ruled out.
Our presented data are relevant for a risk assessment
based SRM definition. At least in younger animals up to
12 mpi the jejunum carries BSE infectivity. A recently
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published quantitative study reported a considerable
amount of lymphoid and neural tissues in natural sau-
sage casing produced from cattle small intestine after
the cleaning procedure [29]. Cross-contaminations
between animals of various ages during the production
process as well as during food preparation cannot be
ruled out. Moreover, it has to be emphasized that only a
very small proportion of the jejunum, (which has an
overall length of 25-30 m and contains up to 40 PP)
was examined in this current study.
In summary our study shows that nearly all of the BSE-
infected cattle that were examined had BSE infectivity
and/or detectable amounts of PrPSc in their small intes-
tines. The highest amounts of BSE infectivity and/or
PrPSc were seen in the ileum and ileocaecal junction with
lower amounts in the jejunum. Clear time-dependent
variations in the detectable amounts of PrPSc were visible.
Younger cattle killed 8 mpi to 12 mpi carried higher
PrPSc levels and had a more widespread distribution of
PrPSc than animals at 16 mpi to 20 mpi. The data from
this study show a more widespread distribution of the
BSE agent in the small intestines in particular of pre-clin-
ical cattle and are the first describing infectivity in jejunal
samples of cattle. Therefore the data presented here are
important for the definition of SRM and the implementa-
tion of their removal as part of functional public health
protection measures against BSE.
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